CRO Intel

Dashboard Companies Opportunity Signals Clinical Trials Hiring Intelligence Funding Publications FDA Settings

Company Intelligence

Discover companies with clinical, regulatory and hiring signals
Total Companies

6,643

Company Clinical Trials FDA Signals Hiring Opportunity Confidence Last Seen
Jiangzhong Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Jianmin Pharmaceutical Group — — —
60
36% 		7/17/2026 View Intelligence
Jiaxing Pharmadax Genesis Pharmaceutical Technology Coltd — — —
60
36% 		7/17/2026 View Intelligence
Jiesi Yingda Pharmaceutical Technology (suzhou) — — —
60
36% 		7/17/2026 View Intelligence
Jin Yang Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Jina Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Jinan Hetai Pharmaceutical Technology — — —
60
36% 		7/17/2026 View Intelligence
Jkt Biopharma — — —
60
36% 		7/17/2026 View Intelligence
John Papastergiou Pharmacy — — —
60
36% 		7/17/2026 View Intelligence
Johnson & Johnson Pharmaceutical Research & Development 9 trials — —
90
36% 		7/17/2026 View Intelligence
Joincare Pharmaceutical Group Industry — — —
60
36% 		7/17/2026 View Intelligence
Joint Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Jomaa Pharma — — —
60
36% 		7/17/2026 View Intelligence
Jounce Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Journey Medical — — —
60
40% 		7/20/2026 View Intelligence
Jubilant Cadista Pharmaceuticals — — —
60
44% 		7/20/2026 View Intelligence
Jubilant Cadista Pharmacuticals — — —
60
40% 		7/20/2026 View Intelligence
Jubilant Draximage (USA) — — —
60
39% 		7/20/2026 View Intelligence
Jubilant Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Julie Products — — —
60
40% 		7/20/2026 View Intelligence
Julphar Gulf Pharmaceutical Industries — — —
60
36% 		7/17/2026 View Intelligence
June Jacobs Labs — — —
60
42% 		7/20/2026 View Intelligence
Jungsaemmool Beauty — — —
60
42% 		7/20/2026 View Intelligence
Juniper Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Juno Therapeutics A Bristol-myers Squibb — — —
60
36% 		7/17/2026 View Intelligence
Juno Therapeutics A Subsidiary Of Celgene — — —
60
36% 		7/17/2026 View Intelligence
Junshi Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Jupiter Orphan Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Just Brands — — —
60
40% 		7/20/2026 View Intelligence
Juvantia Pharma — — —
60
36% 		7/17/2026 View Intelligence
Juvena Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Juventas Therapeutics 1 trials — —
60
36% 		7/17/2026 View Intelligence
Jw Pharmaceutical 8 trials — —
60
36% 		7/17/2026 View Intelligence
J~pharma 3 trials — —
60
36% 		7/17/2026 View Intelligence
K C Pharmaceuticals — — —
60
46% 		7/20/2026 View Intelligence
K-group Alpha A Wholly Owned Subsidiary Of Zentalis Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
K-group Beta A Wholly Owned Subsidiary Of Zentalis Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
K-pax Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
K36 Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
K7 DESIGN GROUP — — —
60
40% 		7/20/2026 View Intelligence
KAS Direct dba BabyGanics — — —
60
42% 		7/20/2026 View Intelligence
KENDO HOLDINGS — — —
60
41% 		7/20/2026 View Intelligence
KINGKEY MBC LIFE TECHNOLOGY GROUP — — —
60
42% 		7/20/2026 View Intelligence
KLARINA — — —
60
40% 		7/20/2026 View Intelligence
KMM Pharmaceuticals — — —
60
39% 		7/20/2026 View Intelligence
KOBAYASHI Healthcare International — — —
60
40% 		7/20/2026 View Intelligence
KVK-Tech — — —
60
42% 		7/20/2026 View Intelligence
KW ABSC — — —
60
40% 		7/20/2026 View Intelligence
KYNC DESIGN — — —
60
42% 		7/20/2026 View Intelligence
Kadesh Incoporation — — —
60
42% 		7/20/2026 View Intelligence
Showing 3151 - 3200 of 6,643 companies